MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Funding Opportunities: Pioneers, Architects & Consolidators
Funding: Strategic Corporate Investment & Corporate Venture Capital (CVC)
Google Ventures (GV) - #4 Most Active Digital Health Strategic Corporate Investor (2014)
*Finance & Acquisition: Google Ventures (GV)
WatchList: Closing, Closed, Inactive, Liquidation, Dissolution or Out of Business
2025: The 2025 Biotech Graveyard
iTeos Therapeutics Inc. (NASDAQ: ITOS)*
Organization & Developments: iTeos Therapeutics
Parents
iTeos Therapeutics Inc. (NASDAQ: ITOS)*
Children
*Iteos Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of immuno-oncology therapeutics for cancer patients.
2023: iTeos Therapeutics: Trying Hard Where The Big Guys Might Still Fail_seekingalpha.com
2024: iTeos Therapeutics: A Perhaps Unjustified Decline To End 2024
2024: iTeos Therapeutics: ESMO Data Showing Signs Of A Real Win For TIGIT
2024: iTeos: Readouts From TIGIT And Adenosine Pathway Inhibitors Makes This A Must Watch
2024: TIGIT drug from iTeos shrinks lung tumors in trial
2025: iTeos Therapeutics Announces Its Intention to Wind Down Operations
2025: iTeos Therapeutics: Decimated By Collateral Events, Good Chances Of Success Nevertheless
2025: iTeos Therapeutics: End To Belrestotug Program Leads To A Hold Rating
2025: iTeos Therapeutics: TIGIT Falls, And A Zombie Rises?
Jumps
Finance & Acquisitions: iTeos Therapeutics
Key People: iTeos Therapeutics